Alzamend Neuro, Inc. (Nasdaq: ALZN) announced that an abstract reporting resting-state functional magnetic resonance imaging findings for its AL001 lithium ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE